Davary Avareshk A, Jalal R, Gholami J
Med Oncol. 2022; 39(12):194.
PMID: 36071289
DOI: 10.1007/s12032-022-01787-9.
Esfandiari Mazandaran K, Mirshokraee S, Didehban K, Houshdar Tehrani M
Iran J Pharm Res. 2020; 18(4):1823-1830.
PMID: 32184849
PMC: 7059074.
DOI: 10.22037/ijpr.2019.111721.13319.
Mehrotra R, De Gaudio R, Palazzo M
Intensive Care Med. 2004; 30(12):2145-56.
PMID: 15536528
DOI: 10.1007/s00134-004-2428-9.
Alam M, Hershberger E, Zervos M
Curr Infect Dis Rep. 2002; 4(5):426-432.
PMID: 12228030
DOI: 10.1007/s11908-002-0010-6.
Berning S
Drugs. 2001; 61(1):9-18.
PMID: 11217874
DOI: 10.2165/00003495-200161010-00002.
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, trovafloxacin, and ciprofloxacin.
Hoppe J, Dalhoff A, Pfrunder D
Antimicrob Agents Chemother. 1998; 42(7):1868.
PMID: 9661039
PMC: 105701.
DOI: 10.1128/AAC.42.7.1868.
The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.
Dan M, Torossian K, WEISSBERG D, Kitzes R
Eur J Clin Pharmacol. 1993; 44(1):101-2.
PMID: 8436147
DOI: 10.1007/BF00315290.
Determination of pefloxacin concentration in mesenteric lymph nodes by high-performance chromatography.
Munera M, Cuesta F, Abadia A, Vasquez J, Restrepo M
Antimicrob Agents Chemother. 1994; 38(3):632-4.
PMID: 8203867
PMC: 284512.
DOI: 10.1128/AAC.38.3.632.
Prediction of brain delivery of ofloxacin, a new quinolone, in the human from animal data.
Kawakami J, Yamamoto K, Sawada Y, Iga T
J Pharmacokinet Biopharm. 1994; 22(3):207-27.
PMID: 7884650
DOI: 10.1007/BF02353329.
Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis.
Skinner P, Furney S, Kleinert D, Orme I
Antimicrob Agents Chemother. 1995; 39(3):750-3.
PMID: 7793885
PMC: 162617.
DOI: 10.1128/AAC.39.3.750.
Fluoroquinolones and surgical prophylaxis.
Dellamonica P, Bernard E
Drugs. 1993; 45 Suppl 3:102-13.
PMID: 7689440
DOI: 10.2165/00003495-199300453-00018.
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.
Hoppe J, Simon C
Antimicrob Agents Chemother. 1990; 34(11):2287-8.
PMID: 2073123
PMC: 172042.
DOI: 10.1128/AAC.34.11.2287.
Penetration of ofloxacin into human lung tissue following a single oral dose of 200 milligrams.
Serour F, Dan M, Gorea A, Yellin A, Lieberman Y, Berger S
Antimicrob Agents Chemother. 1991; 35(2):380-1.
PMID: 2024972
PMC: 245011.
DOI: 10.1128/AAC.35.2.380.
A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection.
Yoshioka K, Youngs D, Keighley M
Infection. 1991; 19(1):25-9.
PMID: 2013505
DOI: 10.1007/BF01643754.
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin.
Rastogi N, Goh K
Antimicrob Agents Chemother. 1991; 35(9):1933-6.
PMID: 1952872
PMC: 245298.
DOI: 10.1128/AAC.35.9.1933.
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages.
Rastogi N, Labrousse V, Goh K, de Sousa J
Antimicrob Agents Chemother. 1991; 35(12):2473-80.
PMID: 1667250
PMC: 245415.
DOI: 10.1128/AAC.35.12.2473.
Ofloxacin clinical pharmacokinetics.
Lamp K, Bailey E, Rybak M
Clin Pharmacokinet. 1992; 22(1):32-46.
PMID: 1559306
DOI: 10.2165/00003088-199222010-00004.
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
Kovarik J, Hoepelman A, Smit J, Sips P, Rozenberg-Arska M, GLERUM J
Antimicrob Agents Chemother. 1992; 36(11):2458-61.
PMID: 1336948
PMC: 284353.
DOI: 10.1128/AAC.36.11.2458.
In vitro activities of five quinolones against Chlamydia pneumoniae.
Hammerschlag M, Hyman C, Roblin P
Antimicrob Agents Chemother. 1992; 36(3):682-3.
PMID: 1320366
PMC: 190581.
DOI: 10.1128/AAC.36.3.682.
The quinolones. An overview of their pharmacology.
Fitton A
Clin Pharmacokinet. 1992; 22 Suppl 1:1-11.
PMID: 1319865
DOI: 10.2165/00003088-199200221-00003.